Medtronic's In.Pact AV DCB Compared to PTA at 36 Months in IN.PACT AV Access Study - Endovascular Today
New Data Supports Medtronic's Drug-Coated Balloon in Wake of Recall | mddionline.com
New MEDTRONIC ADM05004008P In.Pact Admiral Paclitaxel-Coated PTA Balloon Catheter, 5.0mm x 40mm, 80cm (X) Disposables - General For Sale - DOTmed Listing #3519528:
IN.PACT Admiral Drug-Coated Balloon Animation - YouTube
Drug-coated Balloon-only Angioplasty for Native Coronary Disease Instead of Stents | ICR Journal
Drug-coated In.Pact Admiral Balloon Cleared for Longer Lesions | DAIC
France: New cut on the liste en sus (V): In.Pact, Admiral, Medtronic, Drug Coated Balloon (DCB)
New MEDTRONIC In-Pact Admiral Paclitaxel-Coated PTA Balloon Catheter 4mm x 80mm x 130cm (X) ADM04008013P Disposables - General For Sale - DOTmed Listing #2847198:
Clinical Studies Show Medtronic Drug Coated Balloon Outperforms Bare Metal Stents; Maintains Performance in Real World | DAIC
Medtronic Drug-Coated Balloons
Medtronic Vascular, ADM06015013P, 6.00mm, Medtronic IN.PAC... - eSutures
Drug Eluting Balloon Market Size, Growth, Trends and Forecast to 2028 | Medtronic, Becton, Boston Scientific Corporation | Medgadget
Current Use of Coronary Drug-Coated Balloons - Cardiac Interventions Today
Medtronic warns on Prevail drug-coated PTCA balloon catheter
Medtronic delivers 5-year data for its drug-coated balloon for PAD, compared to drugless angioplasty | Fierce Biotech
Medtronic Gains Health Canada Licence For Drug-Coated Balloon | Medical Product Outsourcing
FDA adcom to pronounce on paclitaxel-coated devices | Evaluate
The latest on the prevail drug-coated balloon
Recent FDA Approvals for Drug-eluting Balloons - Drug-eluting Balloons
endovascular.es
Medtronic's IN.PACT Admiral Drug-Coated Balloon Approved To Treat Long SFA Lesions | Medical Product Outsourcing
FDA Clears Medtronic Drug-Coated Balloon to Treat Arteriovenous Fistula Lesions | DAIC
Drug loss from Paclitaxel-Coated Balloons During Preparation, Insertion and Inflation for Angioplasty: A Laboratory Investigation | SpringerLink
US FDA approves first drug-coated balloon for treatment of in-stent restenosis - Vascular News
Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions | Circulation: Cardiovascular Interventions
